Fumie Fujisawa

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Cancers

Future oncology (London, England)

Thoracic cancer

Cancer medicine

Osaka International Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka International Cancer Institute Jan 01 2016

Japan

Vice Director :: Department of Medical Oncology

Publications

Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa, Sachiko Yamamoto, Toru Wakamatsu, Takuji Hayashi, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Tomoyuki Yamasaki, Keiichirou Honma, Kazuyoshi Ohkawa
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 15 (3) (2023)
Hiroki Kusama, Nobuyoshi Kittaka, Ai Soma, Azusa Taniguchi, Haruka Kanaoka, Satomi Nakajima, Yuri Oyama, Yukiko Seto, Jun Okuno, Noriyuki Watanabe, Saki Matsui, Minako Nishio, Fumie Fujisawa, Keiichirou Honma, Yasuhiro Tamaki, Takahiro Nakayama
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer. Breast cancer (Tokyo, Japan) (2023)
Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa, Sachiko Yamamoto, Toru Wakamatsu, Takuji Hayashi, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Tomoyuki Yamasaki, Keiichirou Honma, Kazuyoshi Ohkawa
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 15 (3) (2023)
Mizuki Kato, Kayo Nakata, Toshitaka Morishima, Yoshihiro Kuwabara, Fumie Fujisawa, Nobuyoshi Kittaka, Takahiro Nakayama, Isao Miyashiro
Fifteen-year survival and conditional survival of women with breast cancer in Osaka, Japan: A population-based study. Cancer medicine (2023)
Kei Kunimasa, Naotoshi Sugimoto, Takahisa Kawamura, Tomoyuki Yamasaki, Keiichirou Honma, Shigenori Nagata, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Mitsuko Kitasaka, Toru Wakamatsu, Takuo Yamai, Sachiko Yamamoto, Takuji Hayashi, Takako Inoue, Motohiro Tamiya, Fumio Imamura, Kazuo Nishimura, Kazumi Nishino
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study. Thoracic cancer 13 (21) (2022)
Norikazu Masuda, Tetsuhiro Yoshinami, Masahiko Ikeda, Makiko Mizutani, Miki Yamaguchi, Yoshifumi Komoike, Tsutomu Takashima, Katsuhide Yoshidome, Junji Tsurutani, Mitsuhiko Iwamoto, Fumie Fujisawa, Hiroyuki Yasojima, Jun Yamamura, Hirotaka Morishima, Fuminori Aki, Tomomi Yamada, Satoshi Morita, Takahiro Nakayama
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214. Cancers 13 (17) (2021)
Takahiro Nakayama, Fumie Fujisawa
Therapy options after CDK4/6 inhibitors for HR+, HER2- postmenopausal metastatic/recurrent breast cancer in Japan: a role for mammalian target of rapamycin inhibitors? Future oncology (London, England) 16 (24) (2020)

Fumie Fujisawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fumie Fujisawa